Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of ...